BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 5, 2017
View Archived Issues
Fluvoxamine maleate approved in Japan for pediatric obsessive-compulsive disorder
Read More
Taivex initiates phase I study of T-1101 in advanced refractory solid tumors
Read More
Spinraza approved in Japan and Canada
Read More
Kyowa Hakko Kirin initiates phase III trial of mogamulizumab in HTLV-1 associated myelopathy
Read More
Evidence of activity seen with BGB-A317 in hepatocellular carcinoma
Read More
FDA accepts for review resubmission of SUN-101/eFlow NDA
Read More
PET using [18F]CTT-1057 effectively images prostate cancer
Read More
VenatoRx Pharmaceuticals describes novel beta-lactamase inhibitors
Read More
Pfizer divulges new GABA(A) receptor modulators
Read More
Rice University patents CJ-16264 analogues
Read More
Bayer Pharma describes new potassium channel subfamily K member 3/9 blockers
Read More
Novel complement factor D inhibitors discovered at Lifesci Pharmaceuticals
Read More
New hBUB1 inhibitors synthesized at Bayer Pharma
Read More
Onxeo reports preclinical proof-of-concept results for intravenous AsiDNA
Read More
TIM-3 and Gal-9 found to impact disease outcome in myelodysplastic syndromes
Read More
Saniona acquires NeuroSearch's remaining interest on acquired assets
Read More
M Pharmaceutical adds potential pediatric orphan drug to pipeline
Read More
New phase II trial explores use of filgotinib in noninfectious uveitis
Read More
Amenalief approved in Japan to treat herpes zoster
Read More
Zydus initiates phase II trial of ZYAN-1 to treat anemia in chronic kidney disease
Read More
Daiichi Sankyo discontinues Japanese development of etanercept biosimilar CHS-0214
Read More
Human adipose-derived stromal cells effectively treat experimental glomerulonephritis
Read More
Lytix advances phase I trial of LTX-315
Read More
Updated phase I/II data for KTE-C19 in pediatric relapsed/refractory acute lymphoblastic leukemia
Read More